Sartorius Stedim Biotech S.A.
SDMHF
$192.00
$0.500.26%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | 3.15B | 3.07B | 3.01B | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | 3.15B | 3.07B | 3.01B | |
| Cost of Revenue | -- | 1.74B | 1.72B | 1.70B | |
| Gross Profit | -- | 1.41B | 1.34B | 1.30B | |
| SG&A Expenses | -- | 723.11M | 703.96M | 702.98M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | 34.24M | 24.44M | 18.13M | |
| Total Operating Expenses | -- | 2.66B | 2.61B | 2.58B | |
| Operating Income | -- | 490.51M | 456.47M | 427.74M | |
| Income Before Tax | -- | 309.05M | 274.46M | 237.04M | |
| Income Tax Expenses | -- | 63.17M | 54.01M | 44.26M | |
| Earnings from Continuing Operations | -- | 245.88 | 220.45 | 192.78 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -1.42M | -2.49M | -3.68M | |
| Net Income | -- | 244.47M | 217.96M | 189.10M | |
| EBIT | -- | 490.51M | 456.47M | 427.74M | |
| EBITDA | -- | 757.15M | 714.89M | 680.69M | |
| EPS Basic | -- | 2.50 | 2.25 | 1.95 | |
| Normalized Basic EPS | -- | 1.16 | 0.95 | 0.95 | |
| EPS Diluted | -- | 2.50 | 2.25 | 1.95 | |
| Normalized Diluted EPS | -- | 1.16 | 0.95 | 0.95 | |
| Average Basic Shares Outstanding | -- | 391.81M | 387.73M | 387.70M | |
| Average Diluted Shares Outstanding | -- | 391.81M | 387.73M | 387.70M | |
| Dividend Per Share | -- | 0.74 | 0.74 | 0.74 | |
| Payout Ratio | -- | 31.15% | 33.14% | 38.19% | |